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INTRODUCTION
Autohemotherapy, that is the intramuscular or subcutaneous injection of
the patient's own freshly drawn venous blood, has been used by physicians
for almost forty years in many different diseases, either as the sole therapy
or as the supplementary or complementary therapy. However, no objectively
measurable physiologic or therapeutic effects of autoblood have as yet been
demonstrated. It is the purpose of this study to present evidence that auto-
hemotherapy acts as a mild stimulant of the adrenal cortex which results in an
increased secretion of its hormones. The change in number of circulating blood
eosinophils was selected as the index for measuring this stimulation.
The question whether autohemotherapy has therapeutic value is not within the scope
of this paper. Numerous articles have been written on this controversial subject. In the
field of dermatology, Wright (58), O'Leary (38), Low (35), and Jones and Alden (27), have
summarized their own experiences and the experiences of others with this therapy. The
consensus of those who believe that autohemotherapy has therapeutic value is that the
best results are observed in psoriasis, herpes zoster, recurrent herpes simplex and chronic
urticaria.
Since it was first introduced by Ravaut (42) in 1913, many theories have been propounded
to explain the action of autohemotherapy. Schamberg and Brown (47) came to the con-
clusion that it 'stimulated an increase in lipolytic and proteolytic activity of the blood
serum.' Hirsch (22) was of the opinion that the breakdown products of the blood acted
on the vegetative nervous system and stimulated the bone marrow. Linser (quoted by
Fox (16)) suggested that the beneficial results in psoriasis might have a connection with
the eosinophil cells since the number of these cells decreased as the eruption improved.
The most frequently mentioned theory was the rather vague statement that autohemo-
therapy stimulates an increased production of antibodies which enables the patient to
become desensitized or immunized (5) (17) (35).
In 1946, Selye, in his classic article on 'The General Adaptation Syndrome' (49), sug-
gested that non-specific therapy might be closely related to the 'alarm reaction' phase of
his adaptation syndrome. He defined the general adaptation syndrome as 'the sum of all
the non-specific systemic reactions of the body which ensue upon long-continued exposure
to stress.' These systemic reactions following exposure to stress can be divided into three
stages: (1) the alarm reaction stage, (2) the stage of resistance, and (3) the stage of ex-
haustion. The present paper will be concerned only with the changes in the body occurring
after acute stress, autohemotherapy in this case, as seen in the 'alarm reaction' stage.
The alarm reaction is a defense mechanism which results in increased resistance not
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only against the agent with which the reaction was elicited, but also to stimuli of a different
nature. This resistance is made possible by the increased production and mobilization of
sugar, chlorides, sodium, a rise in body metabolism and temperature, and a leukocytosis,
to mention but a few of the changes known to occur.
Many agents and conditions have been shown capable of producing the typical alarm
reaction in man and animals. A partial list of these includes electrically induoed con-
vulsions (7) (24) (37), surgery (31), insulin (19) (31) (45), exposure to cold (13) (30) (50),
heat (41) (50), starvation (28) (39), exercise (25), bacterial infections (32) (40), and in-
jections of ammonium chloride (29), sodium bicarbonate (33), formaldehyde (20), typhoid
vaccine (8) (48), and epinephrine (10) (12) (18) (19) (24) (31) (36) (37).
Hematologic Changes in the Alarm Reaction
One of the best indices of the existence of the alarm reaction have been cer-
tain changes in the number of circulating leukocytes (9). The changes reported
most consistently as occurring in the first 3—4 hours after the start of the reac-
tion are (1) an immediate decrease in the total white cell count followed by a more
definite increase due to a neutrophilic leukocytosis, (2) an immediate increase
in lymphocytes followed by a decrease, and (3) a fall in eosinophils.
Although these hematologic changes following non-specific stress have been
studied for many years and have recently been integrated into part of the adap-
tation syndrome by Selye, the exact mechanism of their production was unknown.
The solution of this problem was further advanced when Dougherty and White
(10) (57) and Thorn, Forsham and their co-workers (23) (51) (52) (53) found
that certain adreno-cortical hormones elicit the same hematologic changes. These
hormones are the 1 1-17-oxysteroid hormones of the adrenal cortex, which include
Kendall's Compound E (17-hydroxy-1 1-dehydrocorticosterone) and Compound
F (17-hydroxycorticosterone).
The above workers also showed that the same hematologic changes, occurring
after administration of the adreno-cortical hormones, will ensue also follow-
ing the injection of the pituitary adrenocorticotrophic hormone (ACTH) pro-
vided that the adrenal cortex is functioning normally. The mechanism of action
of the ACTH is that it stimulates the intact adrenal cortex to release the 11-17-
oxysteroids, which in turn influence the circulating blood cells. If there is adrenal
cortical insufficiency though, as in Addison's disease, the hematologic changes
which normally follow administration of ACTH do not occur. On the basis of
this finding a test for adrenal cortical function was developed by Thorn and his
co-workers (52). Among the hematologic changes occurring after injection of
ACTH, the fall in circulating eosinophils was found to be the most consistent
and pronounced. Therefore, this change in the eosinophil count was selected as a
relatively reliable test of adreno-cortical stimulation.
According to this test, normal subjects and patients with diseases not in-
volving the adrenal cortex exhibit at least a 50% fall in the number of circulating
eosinophils 4 hours after the injection of 25 mgm. of ACTH. As an additional
criterion, they stated that the urinary excretion of uric acid and creatinine,
expressed as a ratio, should increase at least 50% to indicate an adequate adrenal
cortical reserve.
It is evident that if autohemotherapy causes an adrenal cortical stimulation,
the count of circulating eosinophils before and after its administration should
be one measure of its activity.
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The hematologic changes which occur after autohemotherapy have been
studied by a few observers, but to our knowledge almost nothing has been
written about its effect on the eosinophil count. A lack of uniformity has oc-
curred in the work of various authors with regard to the size of the dose, the
site of injection (subcutaneous or intramuscular) and the time interval between
the injection and the blood counts. For this reason, a correlation of their various
hematological findings with each others as well as with our own, is rendered dif-
ficult. But the following reports, which make no mention of the eosinophils, can
be correlated to some degree with our series.
Burgess, in 1932, (4) studied the effect on the leukocyte count following the intramuscu-
lar injection of 10 cc. of autoblood in 9 subjects, three of which were normal controls. In
every case, he observed a mild leukocytosis within two hours. He compared these changes
with the normal hourly fluctuations of the leukocytes reported by Sabin (46) and, finding
that they were similar, concluded that the blood changes noted by him following autohemo-
therapy were of minimal significance.
Smirnoff (cited by Frielich and Coe (17)) found that immediately after the injection of
autoblood there occurred a decrease in the number of leukocytes which was maximal in
20 minutes and returned to normal figures in 1 to 14 hours. Later on, there was a relative
increase in the neutrophils with a relative or absolute decrease in the lymphocytes.
In conducting the experiments to be reported here, it was deemed advisable
for control purposes to compare the changes seen after autohemotherapy with
those seen following administration of an agent which is known to stimulate
the adrenal cortex. Since AUTH was not available to us at the beginning of
our studies, epinephrine was selected for this purpose. It is known to initiate
the blood changes seen in the alarm reaction, including the fall in circulating
blood eosinophils.
The eosinopenia that has occurred following the injection of epinephrine
has been known for a long time but has not been studied as intensively as the
other hematologic changes, mainly for technical reasons. Bertelli and his co-
workers (3) in 1910 produced a considerable eosinopenia in dogs and humans by
subcutaneous and intravenous injections of epiriephrine. This has been repeated
by many investigators, including Godlowski (19), Laragh and Almy (31) and
Recant and her co-workers (44). The literature on the effect of epinephrine on
circulating leukocytes has been ably reviewed by Hortling (24) and Michael (37).
The mechanism by which epinephrine injections, or non-specific stress, cause
the release of adrenal cortical hormones is thought to involve the hypothalamus.
Hume (26) found evidence which suggested that a hormonal mechanism is lo-
cated in the anterior hypothalmus which, when activated by stress, releases a
substance capable of causing an increased secretion of ACTH by the anterior
pituitary. The AUTH in turn stimulates the adrenal cortex.
EXPERIMENTAL
Subjects: The studies were carried out on 20 subjects. Eight of these were nor-
mal ambulatory volunteers and 12 were hospitalized dermatologic patients.' Two
additional subjects were used for the urinary tests.
1 Hospitalized on the Service of Dermatology and Syphilology at the New York Uni-
versity Hospital.
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Experimental Technics, Injections, etc.
The procedure used in these tests was essentially the same as that proposed by Thorn,
et al. (52) for testing adrenal cortical function, except that autoblood, epinephrine and
saline were substituted for ACTH as the test drug. Recant et al. (44), from Thorn's labora-
tory, reported on the eosinophil response to administration of epinephrine using this same
procedure.
In the 12 hour period preceding the test, no food or drugs were taken by the subjects,
but drinking of water was permitted as desired except during the morning of the test when
200 cc. of water was taken at 8 and 10 a.m. and 12 noon by each subject. The first of blood
studies was done at 10 a.m. and then the subject was given the injection of autoblood,
epinephrine or saline. Following Laragh and Almy's work (31), we did the second blood
study 3 hours after the injection instead of 4 hours2; and in addition, we did a third blood
count at 6 hours on the majority of subjects. Thus, the blood studies were repeated at 1
p.m. and at 4 p.m. The first urine specimen was collected from 8 to 10 am, and the second
urine specimen from 11 am. to 2 p.m. No food was taken until after 2 p.m.
In the tests with autoblood, 10 cc. of blood was withdrawn from an antecubital vein and
immediately injected intramuscularly in the buttocks. In the control test with epinephrine,
0.5 cc. of a 1:1000 solution of epinephrine hydrochloride (0.5 mgm) was injected subcuta-
neously. In the control test with saline, 10 cc. of physiological saline was injected intra-
muscularly.
Both the test with autoblood and the test with epinephrine were done on all of the 20
subjects. The test with saline was done on 5 of the subjects. The uric acid and creatinine
excretion studies were done on 9 of the group of 20 subjects and on 2 additional subjects,
i.e. a total of 11 subjects.
The test with autoblood was done as the first test of the series on 6 subjects and the
test with epinephrine was done first on the remaining 14 subjects. This procedure of re-
versing the sequence was adopted in an attempt to eliminate possible errors which could be
the result of the second test being in some manner influenced by the first test.
Early in our studies, it was found that if the second test injection was given 2 to 5 days
after the first, the fall in circulating eosinophils would not be as great as expected; and
indeed, in some cases there would even be a rise in eosinophils. This seemed to indicate
that with stimuli of the order of magnitude employed by us, there was a refractory period
following stimulation of the adrenal cortex which precluded later response until the organs
responsible for the blood changes had recovered from the effects of the first stimulation.
Michael (37) has stressed the importance of this refractory period. Among others, he cites
the work of Loeper and Crouzon (34) to support this contention. They showed that admin-
istration of 1 mgm. of epinephrine in man produced a leukocytosis persisting for four days.
On the basis of these reports and our own findings an arbitrary interval of 7 days was
established between the tests with autoblood, epinephrine, or saline on any one patient.
The exception to this rule was a series of tests in which autoblood or epinephrine injections
were given daily.
Treatment with autoblood usually consists of a series of injections given at time intervals
of one to seven days. The most accepted dermatologic office procedure is to give autohemo-
therapy once or twice a week, usually along with other modalities of treatment. In hospital-
ized patients, it is possible to be more intensive with respect to autohemotherapy. If one
2 Comparative counts have been done at 3 and 4 hours following the injections of auto-
blood in 0 cases, and following epinephrine in 10 cases. Of the total of 16 cases, the 4 hour
count showed a further fall from the 3 hour count in 9 cases, a rise over the 3 hour count in 6
cases and no change in 1 case. When the expected counting errors are taken into consider-
ation, there is no essential difference between the 3 and 4 hour counts in our experience.
Therefore, our figures at 3 hours are probably comparable with other investigators' figures
at 4 hours.
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assumes that the beneficial action of autoblood therapy is due to stimulation of the adrenal
cortex, it would seem likely that the best clinical results will be seen if the injection is
given more frequently. Since one daily injection would probably be the most intensive
regime that would still be agreeable and comfortable to the patient, 8 patients were studied
after being given 10 cc. of autoblood daily at 10 am. The injections were continued for from
4 to 10 days. The hematologic routine on the first day of treatment was the same as out-
lined for the single injection tests. Patients were not made to fast on the following days.
Procedures for hematologic tests
Total leukocyte counts, differential counts and eosinophil counts were done
from venous blood placed in balanced oxalate (56), except for one subject who had
peripheral blood taken from the finger.
The total leukocyte count was done in the routine manner. Blood smears,
made from a drop on the end of the needle, were stained with Wright's stain and
200 cells were counted. The eosinophils were counted in a special Levy counting
chamber with the Fuchs-Rosenthal ruling and a depth of 0.2 mm. The oxalated
blood was drawn into a regular white cell counting pipette up to the 0.5 mark and
diluted 1:20 with a modification of the fluid proposed by Dunger (11) .The
pipette was shaken for about 30 seconds and then the chambers were filled. It
took approximately 3 minutes for the eosinophils to take on a distinctive pink
stain.4 The contents of 2 chambers were counted and the average was multiplied
by 6.25. This gave the number of eosinophils in one cubic millimeter. The eosin-
acetate diluent for eosinophil counting proved very satisfactory in our hands
since the principal causes for error, as pointed out by Henneman, et al (21), were
eliminated at the onset.
The changes in the leukocytes, both absolute and relative, occurring at 3 and
6 hours after the injections were computed as the percent change from the pre-
injection count. The neutrophil count included any band forms that were present.
The changes in circulating monocytes and basophils were not analyzed.
Barnett (2) found that when 200 cells are counted for the differential of neutro-
phils and lymphocytes, the maximum chance error was around 12%. Therefore,
it was arbitrarily decided in our tests that any average percentage change in the
absolute or relative counts of any of the leucocytes that did not exceed 15%
would not be considered a statistically significant change.
The two specimens of urine were examined for uric acid by the method of
Benedict and Franke (6) and for creatinine by Folin's method (14). Then the uric
acid-creatinine ratio was computed. The urine studies were run concurrently only
with the first test of the series on a patient.
Eosin, aqueous, 2% 5 cc.
Acetone 5 cc.
Distilled water, q. s. ad 100 cc.
This was filtered before use and stored in an icebox. It was prepared fresh every two
weeks.
The pink staining eosinophil can best be seen with the diaphragm of the microscope
opened to give maximum light. Under these conditions, the eosinophils also appear re-
fractile.
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RESULTS
Hematologic Studies
The average fall in circulating eosinophils 3 and 6 hours after an intramuscular
injection of 10 cc. of autoblood was 41% (±21%) and 43% (±21%) respec-
tively.5 The average fall in eosinophils 3 and 6 hours after a subcutaneous injec-
tion of 05 mgm. of epinephrine was 50% (±17%) and 52% (±18%) respec-
tively (Figure 1).
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FIG. 1. A comparison of the percentage change in circulating eosinophils occurring 3
and 6 hours after an injection of autoblood, epinephrine or saline. The average change is
represented by the broken line. Each dot represents a test.
Following the autoblood injection, there was an average rise in the absolute
neutrophil count of 16% and 17% at 3 and 6 hours respectively. While there was
a slight tendency toward a rise in the average total leukocyte count and relative
neutrophil count, and toward a fall in the average absolute and relative lympho-
cyte count 3 and 6 hours after the autoblood injection (Figure 2), these changes
were not statistically significant (Table 1).
The changes in the leukocyte count occurring after the injection of epinephrine
were more significant (Table 2). These averaged a 30% and 18% increase in the
total leukocyte count in 3 and 6 hours. There was a 61% and a 40% rise in the
absolute neutrophil count at 3 and 6 hours, and a 24% and 20% rise in the rela-
tive neutrophil count. The average relative lymphocyte count fell 16% and 21%
in 3 and 6 hours, whereas the absolute lymphocyte count was not changed sig-
nificantly (Figure 3).
We are indebted to Dr. H. Krakower for aid in the statistical analyses.
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The injection of 10 cc. of saline intramuscularly in 5 subjects was followed by
an average fall of 8% (± 17%) in eosinophils at 3 hours and, in 3 of the subjects,
a 10% rise (±32%) in 6 hours. At 3 hours there were no significant changes in the
average total leukocyte and neutrophil counts but at 6 hours they rose 55% (+6
to + 105) and 100% (+20 to + 160) respectively. The lymphocytes showed no
essential change (Table 3).
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Urinary Studies
The uric acid-creatinine ratio, as studied in 5 subjects during the test with
autoblood, and in 6 subjects during the test with epinephrine showed no consist-
ent changes. Recant et al. (44) also noted no rise in the uric acid-creatinine ratio
after epinephrine.
The Eosinophil Changes Following Daily Autohemotherapy and Epinephrine
In the 8 subjects who received autoblood injections daily for 4 to 10 days, the
eosinophils on the average fell as described following a single injection and stayed
at a relatively low level during and for 3 to 5 days after the injections. However,
there were considerable fluctuations and the fall in the eosinophil count was not
always maintained. Clinically the dermatoses of 5 patients showed improvement
while under autohemotherapy, but this was not a reliable therapeutic test be-
cause local treatment was used as well. In 3 cases there was no change in the
presenting dermatosis.
Epinephrine, 0.5 mgm. every 6 hours for a period of a week, was given to one
patient with foliaceus pemphigus (Z.E.) and another with generalized psoriasis
with arthropathy (L.S.). There was no improvement in the diseases. Here the fall
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TABLE 2
Percentage changes in the relative and absolute number of circulating leukocytes 3 and 6 hours
after the subcutaneous injection of 0.5 mgm. of epinephrine
% Change after Epinephrine
W.B.C. NSUTRO.
3hr. óhr.
LYMPH. EOS.
CASZ NO.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
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24R
6R
53R
SR
30R
36R
17R
90R
43R
18R
57R
2R
64R
12F
29R
39R
hF
24R
19F
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14R
3R
75R
42R
45R
25R
2F
1OF
13R
27R
16R
21F
hR
Re!. Abs. Re!. Abs.
3 hr.
3 hr. 6 hr. 3 hr. 6 hr. 3 hr. 6 hr. 3 hr. 6 hr.
23R 6R 52R 21R 18F 7F 2R 7R 68F
46R 30R 55R 34R 43F 41F 30F 38F 48F
4R 27R 59R 120R 5F 34F 45R 14R 31F
34R 45R 40R 64R 44F 51F 41F 31F 71F
22R 18R 58R 72R 46F 33F 30F 3F 83F
27R 44R 73R 79R 36F 51F 13F 31F 37F8R 2F 26R 4F 1OF 17R SR 14R 59F
4R 100R 44R 68R 23F
40R 26R 100R 43F 32F 1SF 22F
36R 69R 31F 19F 64F
21R 90R 32F 7R 64F
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Fia. 3. Average per cent change in the relative and absolute number of leukocytes 3
and 6 hours after an injection of epinephrine. (Dotted lines =relative figures.)
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in eosiriophils was more marked and consistent than that seen following daily
autohemotherapy. The magnitude of fall in eosiriophils following multiple in-
jections of autoblood and epinephrine in no way compared with the dramatic and
TABLE 3
The complete data on the relative and absolute number of circulating leukocytes on a repre-
sentative subject ( 5, J.D.) tested with autoblood, epinephrine and saline
TEST EOR W.B.C.
NEUTRO.
Rel. Abs.
L'lS&PH.
Eel. Abs.
EOS.
Autoblood 0
3
6
5300
6300
5000
%
51
70
73
2703
4410
3650
%
41
27
20
2173
1701
1000
144
88
94
Epinephrine 0
3
6
4000
5200
5800
55
67
65
2200
3484
3770
37
20
25
1480
1040
1450
253
44
56
Saline 0
3
6
4000
3800
6200
51
61.5
72
2040
2337
4464
45
25.5
19
1800
869
1178
103
108
99
cko.qe
lift
autobtoed i,t,.ott
100
50
__________________
0
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+44+
+tftf4Y t4Et4Xf4Xf4xt4It
25 5012.5 ___________
FIG. 4. Comparison of eosinophil changes following administration, not concurrently,
of autoblood, epinephrine and ACTH in a representative patient, L. S.
persistent fall which was seen to occur after administration of ACTH (Armour).
Figure 4 illustrates the eosinophil changes in a comparative manner for the 3
different modalities used on one patient. Essentially the same findings with re-
gard to the fall in eosinophils following repeated injections of epinephrine were
observed by Recant et al. (44), Thorn et al. (51) and Loeper and Crouzon (34).
ADRENO-CORTICAL STIMULATION BY AUTOREMOTRERAPY 187
DISCUSSION
The purpose of the work presented was to attempt to ascertain whether evi-
dence could be found that autohemotherapy has a stimulating effect on the
adrenal cortex, i.e. whether it tends to increase the secretion of 1 1-17-oxysteroid
hormones (Figure 5). On the basis of the results of the reported tests it appears
likely that autoblood injections cause a significant fall in the number of circula-
ting eosinophils and a rise in the absolute number of neutrophils. Certainly the
hematologic changes following autohemotherapy qualitatively parallel those ob-
served following injections of epinephrine in the same patients. Also there is no
statistically significant quantitative difference between the percentage fall in
circulating eosinophils seen after the injection of autoblood and after the injec-
tion of epinephrine.
ot%w $*r.*eiM
•lr
1414 LOt toAo.mos
+A6tror ?o.rtj(ACT I-i)
ACTH AdrenaL Cortex
n.jectoi. (Il-ti- oxMsterog)
It-I1-ocHserou boj tssues
FIG. 5. Pathways to increase the amount of adrenal cortical hormones
The saline injections, which were used as controls, did not bring about the
same hematologic changes. This seems to rule out the possibility that the changes
observed were merely due to the trauma or stress produced by the introduction of
the needle or to any other psychic effects of the procedure. This makes it even
more likely that the mechanism of action of autoblood on the adrenal cortex is
qualitatively very similar to that of epinephrine. However, the final proof of the
action of autohemotherapy on the adrenal cortex would have to be brought by
experiments on animals designed to ascertain whether an increased quantity of
cortical hormones can actually be detected in the adrenal vein following autoblood
injections similar to what Vogt found after injections of epinephrine (55).
The question arises then whether the effect of autohemotherapy on the eosino-
phils is mediated through an increased secretion of endogenous epinephrine from
the adrenal medulla. As evidence against this, Recant et al. (44) have shown that
rats whose adrenal medulla had been removed, still reacted normally to an in-
jection of ACTH, i.e. they responded with an eosinopenia. Also, two completely
sympathectomized dogs showed a normal fall in eosinophils 4 hours after the in-
jection of 2 cc. of a 37% solution of formalin intramuscularly. Our present studies
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bring further evidence against epinephrine being a mediator for the effects of
autohemotherapy. We found that in six patients studied, there was no rise in
blood pressure or increase in pulse rate following administration of autoblood. In
fact, in all six cases, there was a slight fall in blood pressure within the first hour.
Epinephrine, in the dose employed, regularly caused an increase in blood pressure
within 15—30 minutes after the injection and also a pronounced tachycardia.
Another fundamental question is the following: If autohemotherapy stimu-
lates the release of the 11-17-oxysteroid hormones from the adrenal cortex, can
one say that the beneficial effects which have been reported in certain diseases
are due to these hormones? It is possible that there may be some other, as yet
undisclosed, action of autoblood on the body and on diseases, but positive and
objective evidence is not available. Nevertheless, our results with single and
multiple injections of autoblood, make it obvious that the degree of stimulation
of the adrenal cortex to cause a fall in circulating eosinophils must be relatively
very small as compared to that effected by the administration of even small doses
of ACTH.
There is, therefore, no definite proof now available that the amount of cortical
hormones released by autohemotherapy is sufficient to account for the beneficial
action occasionally seen from this mode of treatment. Still, since no other physi-
ological action or therapeutic mechanism has so far been proved to result from
autohemotherapy, and since its beneficial value is supported by many physicians
and years of clinical observations, the small amount of cortical hormones released
may be the explanation for the sporadic effectiveness of this form of therapy. It
is quite conceivable that the increased resistance to stress and disease that has
been reported to develop in normal animals following injections of ACTH and
adreno-cortical hormones (43) (54) could be one of the mechanisms of action of
autohemotherapy.
It is possible that there might be a greater fall in eosinophils following injec-
tions of 20 cc. of autoblood, which is double the dose employed in these studies
and is the amount used by many physicians; but it is unlikely that the adrenal
cortical stimulation from even this amount would approach that seen following
administration of ACTH.
SUMMARY
A review is given of the older theories of action of autohemotherapy and of a
newer one correlating it with Selye's 'alarm reaction' and adreno-cortical stimu-
lation. The hematologic changes that ensue during the alarm reaction, of which
the fall in circulating eosinophils is the most consistent, are due to an increase in
secretion of adrenal cortical hormones.
A study of 20 subjects is reported in whom hematologic and urinary tests were
performed following an injection of autoblood and, as controls, of epinephrine
and saline. Epinephrine was used as a drug known to stimulate the adrenal
cortex, and saline as a substance which presumably has no such effect. The results
obtained showed that qualitatively the hematologic changes following autohemo-
therapy and epinephrine were quite similar, and thus represent the first objective
ADRENO-CORTICAL STIMULATION BY ATJTOHEMOTHERAPY 189
evidence of a regularly reproducible effect of autoblood injections. Saline had no
significant effect on the hematologic findings.
Our findings that autohemotherapy regularly causes a fall in the number of
circulating eosinophils in the blood suggest that autohemotherapy stimulates the
adrenal cortex to an increased secretion of the 1 1-17-oxysteroid hormones. A
similar stimulation occurs after the injection of epinephrine.
While there is no definite proof that the presumptive beneficial effect of auto-
hemotherapy on certain diseases is based on stimulation of the adrenal cortex,
the results of the study suggest that this may be the mechanism of action of such
therapy.
We would like to express our appreciation to Dr. Max Wolf and Dr. Max
Jessner who translated the German articles referred to in this report.
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DISCUSSION
DR. CLARENCE LIVIN000D: Has Dr. Sauer studied the effect of blood trans-
fusion in this regard?
DR. MURRAY C. ZIMMERMAN: When the presenters gave their saline, did they
take blood out of the arm and then give saline in the buttocks? How much painful
stimulus was given? It was shown by Pinkus that psychological stress was suffici-
ent to produce this alarm reaction and depress the eosinophil count in normal
people. The psychological effect of seeing blood taken out of the arm and injected
into the hip may be a factor.
I also wonder whether the investigators checked the effect of crude liver, and
of calcium gluconate.
DR. BUTLER: What type of technic was used in staining the eosinophils? Was
it the Thomas stain or the much more accurate method now used?
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DR. DONALD M. PILLSBURY: Dr. Sauer makes the statement in his paper that
many physicians have observed beneficial effects from autohemotherapy. I have
not. I was glad to note that Dr. Saiier has been cautious in his conclusions. Since
he has observed very moderate adrenocortical stimulating effects from auto-
hemotherapy, one might easily fall into the trap of concluding that this would be
a substitute for such therapy. However, the order of magnitude of these effects is
small, and much further work will be required to determine whether or not they
will significantly influence the course of a dermatitis.
Dn. GORDON C. SAUER: (Closing Discussion). I wish to thank the discussors for
their comments. In answer to Dr. Livingood's question whether a similar fall in
eosinophils is known to occur following blood transfusions, I can say that we have
not done any work on that phase, and I have no knowledge of studies by others.
I agree with Dr. Zimmerman that it is possible that the action of many other
non-specific therapeutic agents might be explained by the fact that they stimu-
late the adrenal cortex. To date we have done preliminary studies following intra-
venous calcium gluconate, sodium thiosulfate, strontium bromide and typhoid
fever therapy but have only observed a fall in eosinophils following the typhoid
fever therapy.
The question whether any blood was also withdrawn when we did our control
test with 10 cc. of saline intramuscularly has arisen. All of our blood counts were
done on venal oxalated blood so this necessitated the withdrawal of 5 cc. of blood
in all tests. I don't believe the additional 10 cc. of blood withdrawn concurrently
for the autohemotherapy test would be responsible for the difference in eosinophil
fall observed between this latter test and the saline test.
Dr. Butler asked about the type of stain we used for counting the eosinophils.
We used Thorn's modification of Dunger's eosin-acetone method which, in our
work, we found comparable or superior to Randolph's phloxine-propylene glycol
diluent.
I definitely agree with the statement of Dr. Pillsbury. We must remain cautious
in the interpretation of this evidence of adrenocortical stimulation by autohemo-
therapy. The stimulation that does occur is mild but probably explains in part
why autohemotherapy has remained in the armamentarium of physicians for
many years.
